$OPK
OPKO HEALTH, INC.

2020 Q2 Form 10-Q Financial Statement

#000094480920000033 Filed on July 31, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $301.2M $226.4M
YoY Change 33.06% -14.15%
Cost Of Revenue $162.7M $144.2M
YoY Change 12.83% -3.93%
Gross Profit $138.6M $82.10M
YoY Change 68.82% -27.73%
Gross Profit Margin 46.01% 36.27%
Selling, General & Admin $77.72M $88.48M
YoY Change -12.15% 0.94%
% of Gross Profit 56.08% 107.76%
Research & Development $17.61M $28.29M
YoY Change -37.75% -3.17%
% of Gross Profit 12.7% 34.45%
Depreciation & Amortization $22.27M $23.66M
YoY Change -5.9% -4.45%
% of Gross Profit 16.06% 28.82%
Operating Expenses $274.0M $273.6M
YoY Change 0.15% 1.8%
Operating Profit $27.18M -$47.26M
YoY Change -157.51% 825.22%
Interest Expense -$5.500M -$5.300M
YoY Change 3.77% 1225.0%
% of Operating Profit -20.24%
Other Income/Expense, Net $12.74M -$11.19M
YoY Change -213.85% -237.53%
Pretax Income $39.92M -$58.45M
YoY Change -168.3% -2029.71%
Income Tax $6.028M $1.084M
% Of Pretax Income 15.1%
Net Earnings $33.70M -$59.81M
YoY Change -156.35% 864.46%
Net Earnings / Revenue 11.19% -26.42%
Basic Earnings Per Share $0.05
Diluted Earnings Per Share $0.05 -$102.0K
COMMON SHARES
Basic Shares Outstanding 640.6M shares 615.6M shares
Diluted Shares Outstanding 640.6M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.60M $111.1M
YoY Change -80.56% 38.18%
Cash & Equivalents $21.61M $111.1M
Short-Term Investments
Other Short-Term Assets $19.06M $3.234M
YoY Change 489.24% -32.12%
Inventory $72.97M $48.29M
Prepaid Expenses
Receivables $214.4M $148.3M
Other Receivables $12.70M $18.80M
Total Short-Term Assets $360.1M $344.2M
YoY Change 4.6% 7.05%
LONG-TERM ASSETS
Property, Plant & Equipment $130.5M $137.1M
YoY Change -4.79% -8.69%
Goodwill $671.6M $699.8M
YoY Change -4.04% -2.02%
Intangibles
YoY Change
Long-Term Investments $26.30M $24.30M
YoY Change 8.23% -44.39%
Other Assets $7.487M $3.770M
YoY Change 98.59% -28.14%
Total Long-Term Assets $1.964B $2.112B
YoY Change -7.02% -4.41%
TOTAL ASSETS
Total Short-Term Assets $360.1M $344.2M
Total Long-Term Assets $1.964B $2.112B
Total Assets $2.324B $2.456B
YoY Change -5.39% -2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.67M $60.38M
YoY Change -26.01% -12.58%
Accrued Expenses $210.1M $198.4M
YoY Change 5.91% -1.3%
Deferred Revenue $16.57M $50.39M
YoY Change -67.12% -18.53%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $16.90M $14.30M
YoY Change 18.18% -64.25%
Total Short-Term Liabilities $279.5M $283.4M
YoY Change -1.35% -7.65%
LONG-TERM LIABILITIES
Long-Term Debt $4.201M $4.500M
YoY Change -6.64% 164.08%
Other Long-Term Liabilities $91.65M $127.8M
YoY Change -28.26% -39.0%
Total Long-Term Liabilities $455.8M $463.9M
YoY Change -1.74% 12.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $279.5M $283.4M
Total Long-Term Liabilities $455.8M $463.9M
Total Liabilities $735.4M $747.3M
YoY Change -1.59% 3.73%
SHAREHOLDERS EQUITY
Retained Earnings -$1.538B -$1.337B
YoY Change 15.05% 23.61%
Common Stock $6.704M $6.162M
YoY Change 8.8% 10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.791M $1.791M
YoY Change 0.0% 0.0%
Treasury Stock Shares 549.9K shares 549.9K shares
Shareholders Equity $1.588B $1.709B
YoY Change
Total Liabilities & Shareholders Equity $2.324B $2.456B
YoY Change -5.39% -2.95%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $33.70M -$59.81M
YoY Change -156.35% 864.46%
Depreciation, Depletion And Amortization $22.27M $23.66M
YoY Change -5.9% -4.45%
Cash From Operating Activities -$14.40M -$53.60M
YoY Change -73.13% 213.45%
INVESTING ACTIVITIES
Capital Expenditures -$11.50M -$3.500M
YoY Change 228.57% -48.53%
Acquisitions
YoY Change
Other Investing Activities $100.0K $300.0K
YoY Change -66.67% 0.0%
Cash From Investing Activities -$11.50M -$3.200M
YoY Change 259.38% -51.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.90M -39.30M
YoY Change -132.82% -1082.5%
NET CHANGE
Cash From Operating Activities -14.40M -53.60M
Cash From Investing Activities -11.50M -3.200M
Cash From Financing Activities 12.90M -39.30M
Net Change In Cash -13.00M -96.10M
YoY Change -86.47% 387.82%
FREE CASH FLOW
Cash From Operating Activities -$14.40M -$53.60M
Capital Expenditures -$11.50M -$3.500M
Free Cash Flow -$2.900M -$50.10M
YoY Change -94.21% 386.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2018 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201807Member
CY2018 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2018Q3 opk Number Of Derivative Lawsuits
NumberOfDerivativeLawsuits
12 lawsuit
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentNet
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33528
dei Entity Registrant Name
EntityRegistrantName
OPKO Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2402409
dei Entity Address Address Line1
EntityAddressAddressLine1
4400 Biscayne Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
dei City Area Code
CityAreaCode
(305)
dei Local Phone Number
LocalPhoneNumber
575-4100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
OPK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
669831024 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21612000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85452000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214352000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
134617000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
72965000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
53434000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51125000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50542000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
360054000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
324045000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
130540000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
127111000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
499125000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
528962000 USD
CY2020Q2 opk In Process Researchand Development
InProcessResearchandDevelopment
590200000 USD
CY2019Q4 opk In Process Researchand Development
InProcessResearchandDevelopment
590200000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
671599000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
671940000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
26260000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
20746000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38469000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39380000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7487000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6888000 USD
CY2020Q2 us-gaap Assets
Assets
2323734000 USD
CY2019Q4 us-gaap Assets
Assets
2309272000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
44671000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
62537000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
210111000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
164925000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10298000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12038000 USD
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
14463000 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9619000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
279543000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
249119000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28759000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27665000 USD
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
216457000 USD
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
211208000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
118979000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
118717000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91653000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
87804000 USD
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
455848000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
445394000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
735391000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
694513000 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
670378701 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
670378701 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
6704000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
6704000 USD
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
549907 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
549907 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1791000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1791000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3147030000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3142993000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25752000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22070000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1537848000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1511077000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1588343000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1614759000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2323734000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2309272000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
301207000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
226368000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
512674000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
448820000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77721000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88475000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153852000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
183633000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17608000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28286000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39369000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64816000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1111000 USD
CY2019Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3775000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
251000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1031000 USD
CY2019Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
572000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14937000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16419000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29874000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32981000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
655000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
274028000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
273628000 USD
us-gaap Operating Expenses
OperatingExpenses
526255000 USD
us-gaap Operating Expenses
OperatingExpenses
571397000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27179000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47260000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13581000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-122577000 USD
CY2020Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
5000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
147000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
1127000 USD
CY2020Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
5474000 USD
CY2019Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
5501000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
10970000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
10257000 USD
CY2020Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-13000 USD
CY2019Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-388000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
608000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
27000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18223000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5874000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5890000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4897000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12741000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11191000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4325000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14000000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39920000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-58451000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17906000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-136577000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6028000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1084000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1866000 USD
CY2020Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
33892000 USD
CY2019Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-59535000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-25106000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-138443000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-189000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-271000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-323000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2125000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
33703000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-59806000 USD
us-gaap Profit Loss
ProfitLoss
-25429000 USD
us-gaap Profit Loss
ProfitLoss
-140568000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
640578794 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
586351045 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
640578794 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
586347645 shares
CY2020Q2 us-gaap Profit Loss
ProfitLoss
33703000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-59806000 USD
us-gaap Profit Loss
ProfitLoss
-25429000 USD
us-gaap Profit Loss
ProfitLoss
-140568000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4435000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2878000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3682000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-220000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
38138000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-56928000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-29111000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-140788000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1548619000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1586000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
33703000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4435000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1588343000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1614759000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4037000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25429000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3682000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1588343000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1762737000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3122000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-59806000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2878000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1708931000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1791291000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7579000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-3000 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
50852000 USD
us-gaap Net Income Loss
NetIncomeLoss
-140568000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-220000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1708931000 USD
us-gaap Profit Loss
ProfitLoss
-25429000 USD
us-gaap Profit Loss
ProfitLoss
-140568000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44318000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47477000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
5022000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
2868000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
411000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
308000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-323000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2125000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4037000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7579000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-156000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-220000 USD
opk Increase Decrease In Equity Securities Fvni And Derivative Instruments
IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments
6515000 USD
opk Increase Decrease In Equity Securities Fvni And Derivative Instruments
IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments
-5431000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
251000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1031000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
655000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1028000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
168000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
81539000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4398000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21905000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6225000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2619000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2476000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
61000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-136000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16753000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12887000 USD
opk Increase Decreasein Foreign Currency Measurement
IncreaseDecreaseinForeignCurrencyMeasurement
-2077000 USD
opk Increase Decreasein Foreign Currency Measurement
IncreaseDecreaseinForeignCurrencyMeasurement
131000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4026000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-37015000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
47585000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2095000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57793000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102619000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1200000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
65000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
309000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
17149000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6432000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17084000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7323000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
200293000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7762000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
-3000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
393651000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
39695000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
382374000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
78824000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
28800000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11277000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124599000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-240000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-63840000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14642000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85452000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96473000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21612000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111115000 USD
us-gaap Interest Paid Net
InterestPaidNet
5578000 USD
us-gaap Interest Paid Net
InterestPaidNet
5411000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29900000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-208000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2132000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29640000 USD
opk Operating Lease Liability Initial Recognition Upon Adoption
OperatingLeaseLiabilityInitialRecognitionUponAdoption
0 USD
opk Operating Lease Liability Initial Recognition Upon Adoption
OperatingLeaseLiabilityInitialRecognitionUponAdoption
30049000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
0 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
20000 USD
opk Numberof Sales Employees
NumberofSalesEmployees
300 employee
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000000.0 USD
us-gaap Use Of Estimates
UseOfEstimates
<span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Use of estimates</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</span>
CY2020Q2 opk Covid19 Percent Of Total Test Volume
COVID19PercentOfTotalTestVolume
0.281
us-gaap Inventory Write Down
InventoryWriteDown
1700000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1300000 USD
CY2020Q2 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1800000000 USD
CY2019Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1800000000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
671600000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
671900000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1100000000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1100000000 USD
us-gaap Depreciation
Depreciation
14400000 USD
us-gaap Depreciation
Depreciation
14500000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Concentration of credit risk and allowance for credit losses</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</span>While we have receivables due from federal and state governmental agencies, we do not believe that such receivables represent a credit risk because the related healthcare programs are funded by federal and state governments, and payment is primarily dependent upon submitting appropriate documentation.
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1600000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1900000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000 USD
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
24877 shares
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4000000.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7600000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
0 shares
CY2019Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
0 shares
CY2019Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
0 shares
CY2020Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
0 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
0 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
0 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
19232 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
24877 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
5645 shares
CY2020Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
215925000 USD
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
136551000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1573000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1934000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214352000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
134617000 USD
CY2020Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
41298000 USD
CY2019Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
23005000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
24259000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25142000 USD
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4711000 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3238000 USD
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5826000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4586000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3129000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2537000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
72965000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
53434000 USD
CY2020Q2 opk Taxes Recoverable Current
TaxesRecoverableCurrent
12135000 USD
CY2019Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
19808000 USD
CY2020Q2 us-gaap Supplies
Supplies
12999000 USD
CY2019Q4 us-gaap Supplies
Supplies
8147000 USD
CY2020Q2 us-gaap Prepaid Insurance
PrepaidInsurance
6274000 USD
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3486000 USD
CY2020Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
661000 USD
CY2019Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3262000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
19056000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15839000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51125000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50542000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
327334000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
298234000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
499125000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
528962000 USD
CY2020Q2 opk Inventory Received Not Invoiced Current
InventoryReceivedNotInvoicedCurrent
49005000 USD
CY2019Q4 opk Inventory Received Not Invoiced Current
InventoryReceivedNotInvoicedCurrent
13751000 USD
CY2020Q2 opk Accrued Commitmentsand Contingencies Current
AccruedCommitmentsandContingenciesCurrent
38668000 USD
CY2019Q4 opk Accrued Commitmentsand Contingencies Current
AccruedCommitmentsandContingenciesCurrent
38635000 USD
CY2020Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
34086000 USD
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
33671000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16570000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19196000 USD
CY2020Q2 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
6079000 USD
CY2019Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
8122000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2375000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2375000 USD
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2435000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2743000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4009000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1333000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
56884000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45099000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
210111000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
164925000 USD
CY2020Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
51489000 USD
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
44749000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7559000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7308000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4201000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3906000 USD
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2960000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4046000 USD
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1170000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2571000 USD
CY2020Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
24274000 USD
CY2019Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
25224000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91653000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
87804000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
671940000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-341000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
671599000 USD
CY2020Q2 opk Equity Method Investment Excluding Variable Interest Entity
EquityMethodInvestmentExcludingVariableInterestEntity
561000 USD
CY2020Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
2370000 USD
CY2020Q2 opk Equity Method Investment Variable Interest Entity
EquityMethodInvestmentVariableInterestEntity
836000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
24777000 USD
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
35000 USD
CY2020Q2 opk Stock Optionand Warrant Investments
StockOptionandWarrantInvestments
51000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
26260000 USD
CY2020Q2 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
7900000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
5907000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
5907000 USD
CY2020Q2 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
11 institution
CY2019Q4 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
11 institution
CY2020Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
101312000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
63537000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
52077000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
24777000 USD
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
51000 USD
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
25043000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9934000 USD
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9934000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
18870000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
120000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
19123000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9683000 USD
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9683000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9900000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9700000 USD
CY2020Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
94000 USD
CY2019Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
122000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
160000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9900000 USD
opk Number Of Class Action Lawsuits
NumberOfClassActionLawsuits
2 lawsuit
CY2018Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
100000 USD
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
154200000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
200000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
-14300000 USD
CY2020Q2 opk Accrued Expense Payor Overpayment Reimbursement Liability
AccruedExpensePayorOverpaymentReimbursementLiability
21400000 USD
CY2019Q4 opk Accrued Expense Payor Overpayment Reimbursement Liability
AccruedExpensePayorOverpaymentReimbursementLiability
27300000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17700000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21800000 USD
CY2017Q4 opk Proceeds From Development And License Agreement Upfront Payment
ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment
6000000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 USD
opk Collaborative Arrangement License Termination Written Notice Threshold
CollaborativeArrangementLicenseTerminationWrittenNoticeThreshold
P3M
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27179000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47260000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13581000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-122577000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22266000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23661000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44318000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47477000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-189000 USD
CY2019Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-271000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-323000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-2125000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
301207000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
226368000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
512674000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
448820000 USD
CY2020Q2 us-gaap Assets
Assets
2323734000 USD
CY2019Q4 us-gaap Assets
Assets
2309272000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
671599000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
671940000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38469000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39380000 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5395000 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
6789000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10298000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12038000 USD
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2435000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2743000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28759000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27665000 USD
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2960000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4046000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.039
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.030
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6604000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1404000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7479000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2186000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6506000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1175000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5845000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
590000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4671000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
249000 USD
CY2020Q2 opk Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
17374000 USD
CY2020Q2 opk Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
48479000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
5604000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9422000 USD
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
209000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
39057000 USD
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
5395000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
9700000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1200000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1600000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
9800000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000000.0 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1700000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9804000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
10804000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
86000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
234000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1026000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1590000 USD
opk Payments For Leases
PaymentsForLeases
10916000 USD
opk Payments For Leases
PaymentsForLeases
12628000 USD

Files In Submission

Name View Source Status
0000944809-20-000033-index-headers.html Edgar Link pending
0000944809-20-000033-index.html Edgar Link pending
0000944809-20-000033.txt Edgar Link pending
0000944809-20-000033-xbrl.zip Edgar Link pending
a101viforlicagmtamend.htm Edgar Link pending
a102pfizerlicagmtamend.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opk-20200630.htm Edgar Link pending
opk-20200630.xsd Edgar Link pending
opk-20200630_cal.xml Edgar Link unprocessable
opk-20200630_def.xml Edgar Link unprocessable
opk-20200630_htm.xml Edgar Link completed
opk-20200630_lab.xml Edgar Link unprocessable
opk-20200630_pre.xml Edgar Link unprocessable
opk-6302020xex311.htm Edgar Link pending
opk-6302020xex312.htm Edgar Link pending
opk-6302020xex321.htm Edgar Link pending
opk-6302020xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending